Literature DB >> 9392024

Upper esophageal sphincter myotomy in oculopharyngeal muscular dystrophy: long-term clinical results.

G Fradet1, D Pouliot, R Robichaud, S St-Pierre, J P Bouchard.   

Abstract

From 1980 to 1995, 53 patients with oculopharyngeal muscular dystrophy (OPMD) underwent an upper esophageal sphincter (UES) myotomy for the control of marked dysphagia. From this number, a group of 21 patients had been evaluated for preoperative and postoperative symptoms in 1987. The same clinical assessment was performed in 1995 by an independent evaluator for a total of 37 patients including 12 patients from the first group. As a whole, after a mean follow-up of 6.2 years, surgery succeeded in 18 patients (49%), gave a partial improvement in 12 (32%) and failed in seven (19%). The 12 patients evaluated twice (in 1987 and 1995) have had very good early results, 8-69 months after UES myotomy: dysphagia was totally relieved in eight patients, occurred rarely in three and was moderate in one. Nevertheless, the very long-term follow-up (8 years later) has shown a recurrence of the swallowing and tracheobronchial symptoms in many cases.

Entities:  

Mesh:

Year:  1997        PMID: 9392024     DOI: 10.1016/s0960-8966(97)00090-4

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Successful botulinum toxin treatment of dysphagia in a young child with nemaline myopathy.

Authors:  D A Restivo; S Giuffrida; R Marchese Ragona; R Falsaperla
Journal:  Dysphagia       Date:  2001       Impact factor: 3.438

2.  Botulinum toxin for UES dysfunction: therapy or poison?

Authors:  W J Ravich
Journal:  Dysphagia       Date:  2001       Impact factor: 3.438

3.  Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.

Authors:  Joseph G Manjaly; Peter G Vaughan-Shaw; Oliver T Dale; Susan Tyler; Jonathan C R Corlett; Roger A Frost
Journal:  Dysphagia       Date:  2011-07-30       Impact factor: 3.438

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.